List of Tables
Table 1. Global Adult Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Adult Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Adult Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Adult Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Adult Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Adult Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Adult Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Adult Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Adult Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adult Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adult Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Adult Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adult Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Adult Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Adult Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Adult Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Adult Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Adult Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Adult Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Adult Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Adult Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Adult Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Adult Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Adult Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Adult Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Adult Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Adult Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Adult Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Adult Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Adult Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Adult Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Adult Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Adult Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Adult Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Adult Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Adult Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Adult Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Adult Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Adult Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Adult Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adult Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Adult Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Adult Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Adult Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Adult Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Adult Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Adult Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Adult Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Adult Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Adult Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Adult Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Adult Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Adult Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Adult Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Adult Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Adult Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Adult Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Adult Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Adult Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Adult Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Adult Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Adult Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Adult Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Adult Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Adult Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Adult Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. Solvay Pharmaceuticals Company Information
Table 71. Solvay Pharmaceuticals Description and Business Overview
Table 72. Solvay Pharmaceuticals Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Solvay Pharmaceuticals Adult Vaccines Product
Table 74. Solvay Pharmaceuticals Recent Developments/Updates
Table 75. Moderna Company Information
Table 76. Moderna Description and Business Overview
Table 77. Moderna Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Moderna Adult Vaccines Product
Table 79. Moderna Recent Developments/Updates
Table 80. BioCSL (Seqirus) Company Information
Table 81. BioCSL (Seqirus) Description and Business Overview
Table 82. BioCSL (Seqirus) Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. BioCSL (Seqirus) Adult Vaccines Product
Table 84. BioCSL (Seqirus) Recent Developments/Updates
Table 85. Aventis Pasteur Company Information
Table 86. Aventis Pasteur Description and Business Overview
Table 87. Aventis Pasteur Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Aventis Pasteur Adult Vaccines Product
Table 89. Aventis Pasteur Recent Developments/Updates
Table 90. Sanofi Pasteur Company Information
Table 91. Sanofi Pasteur Description and Business Overview
Table 92. Sanofi Pasteur Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Pasteur Adult Vaccines Product
Table 94. Sanofi Pasteur Recent Developments/Updates
Table 95. Pfizer Inc. Company Information
Table 96. Pfizer Inc. Description and Business Overview
Table 97. Pfizer Inc. Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Inc. Adult Vaccines Product
Table 99. Pfizer Inc. Recent Developments/Updates
Table 100. Merck & Co. Inc. Company Information
Table 101. Merck & Co. Inc. Description and Business Overview
Table 102. Merck & Co. Inc. Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Merck & Co. Inc. Adult Vaccines Product
Table 104. Merck & Co. Inc. Recent Developments/Updates
Table 105. GlaxoSmithKline Plc Company Information
Table 106. GlaxoSmithKline Plc Description and Business Overview
Table 107. GlaxoSmithKline Plc Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Plc Adult Vaccines Product
Table 109. GlaxoSmithKline Plc Recent Developments/Updates
Table 110. Novartis AG Company Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novartis AG Adult Vaccines Product
Table 114. Novartis AG Recent Developments/Updates
Table 115. Johnson & Johnson Company Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Johnson & Johnson Adult Vaccines Product
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. BioNTech Company Information
Table 121. BioNTech Description and Business Overview
Table 122. BioNTech Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. BioNTech Adult Vaccines Product
Table 124. BioNTech Recent Developments/Updates
Table 125. Bharat Biotech International Limited Company Information
Table 126. Bharat Biotech International Limited Description and Business Overview
Table 127. Bharat Biotech International Limited Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bharat Biotech International Limited Adult Vaccines Product
Table 129. Bharat Biotech International Limited Recent Developments/Updates
Table 130. Zhifei Company Information
Table 131. Zhifei Description and Business Overview
Table 132. Zhifei Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Zhifei Adult Vaccines Product
Table 134. Zhifei Recent Developments/Updates
Table 135. Wyeth Vaccines Company Information
Table 136. Wyeth Vaccines Description and Business Overview
Table 137. Wyeth Vaccines Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Wyeth Vaccines Adult Vaccines Product
Table 139. Wyeth Vaccines Recent Developments/Updates
Table 140. AstraZeneca Plc Company Information
Table 141. AstraZeneca Plc Description and Business Overview
Table 142. AstraZeneca Plc Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. AstraZeneca Plc Adult Vaccines Product
Table 144. AstraZeneca Plc Recent Developments/Updates
Table 145. Medimmune Company Information
Table 146. Medimmune Description and Business Overview
Table 147. Medimmune Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Medimmune Adult Vaccines Product
Table 149. Medimmune Recent Developments/Updates
Table 150. Sinovac Company Information
Table 151. Sinovac Description and Business Overview
Table 152. Sinovac Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sinovac Adult Vaccines Product
Table 154. Sinovac Recent Developments/Updates
Table 155. Baxter International Healthcare Company Company Information
Table 156. Baxter International Healthcare Company Description and Business Overview
Table 157. Baxter International Healthcare Company Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Baxter International Healthcare Company Adult Vaccines Product
Table 159. Baxter International Healthcare Company Recent Developments/Updates
Table 160. Chiron Vaccines Company Information
Table 161. Chiron Vaccines Description and Business Overview
Table 162. Chiron Vaccines Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Chiron Vaccines Adult Vaccines Product
Table 164. Chiron Vaccines Recent Developments/Updates
Table 165. Serum Institute of India. Company Information
Table 166. Serum Institute of India. Description and Business Overview
Table 167. Serum Institute of India. Adult Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Serum Institute of India. Adult Vaccines Product
Table 169. Serum Institute of India. Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Adult Vaccines Distributors List
Table 173. Adult Vaccines Customers List
Table 174. Adult Vaccines Market Trends
Table 175. Adult Vaccines Market Drivers
Table 176. Adult Vaccines Market Challenges
Table 177. Adult Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adult Vaccines
Figure 2. Global Adult Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adult Vaccines Market Share by Type: 2024 & 2031
Figure 4. Monovalent Vaccines Product Picture
Figure 5. Multivalent Vaccines Product Picture
Figure 6. Global Adult Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Adult Vaccines Market Share by Application: 2024 & 2031
Figure 8. Private Healthcare Firms
Figure 9. Government Hospitals
Figure 10. Global Adult Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Adult Vaccines Market Size (2020-2031) & (US$ Million)
Figure 12. Global Adult Vaccines Sales (2020-2031) & (K Units)
Figure 13. Global Adult Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 14. Adult Vaccines Report Years Considered
Figure 15. Adult Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Adult Vaccines Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Adult Vaccines Players: Market Share by Revenue in Adult Vaccines in 2024
Figure 18. Adult Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Adult Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Adult Vaccines Sales Market Share by Country (2020-2031)
Figure 21. North America Adult Vaccines Revenue Market Share by Country (2020-2031)
Figure 22. United States Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Adult Vaccines Sales Market Share by Country (2020-2031)
Figure 25. Europe Adult Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. Germany Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Adult Vaccines Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Adult Vaccines Revenue Market Share by Region (2020-2031)
Figure 33. China Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Adult Vaccines Sales Market Share by Country (2020-2031)
Figure 41. Latin America Adult Vaccines Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Adult Vaccines Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Adult Vaccines Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Adult Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Adult Vaccines by Type (2020-2031)
Figure 51. Global Revenue Market Share of Adult Vaccines by Type (2020-2031)
Figure 52. Global Adult Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Adult Vaccines by Application (2020-2031)
Figure 54. Global Revenue Market Share of Adult Vaccines by Application (2020-2031)
Figure 55. Global Adult Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 56. Adult Vaccines Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
